SK-MEL-133 (Q54953819)

From Wikidata

Jump to navigation Jump to search

cell line

SK-Mel-133
SK-Mel 133
SKMEL-133
FF-MEL

Language	Label	Description	Also known as
English	SK-MEL-133	cell line	SK-Mel-133 SK-Mel 133 SKMEL-133 FF-MEL

Statements

1 reference

Cellosaurus release 44

31 January 2023

cancer cell line

1 reference

Cellosaurus release 44

31 January 2023

described by source

Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity

1 reference

Cellosaurus release 44

31 January 2023

Human tumor lines for cancer research.

1 reference

Cellosaurus release 44

31 January 2023

Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15.

1 reference

Cellosaurus release 44

31 January 2023

Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF

1 reference

Cellosaurus release 44

31 January 2023

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

1 reference

Cellosaurus release 44

31 January 2023

established from medical condition

1 reference

Cellosaurus release 44

31 January 2023

derived from organism type

1 reference

Cellosaurus release 44

31 January 2023

Identifiers

1 reference

Cellosaurus release 44

31 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54953819&oldid=1861740947"